Atlanta, GA, United States of America

Yinghsin Hsieh

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Georgia State University Research Foundation, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yinghsin Hsieh. Retrieved from https://idiyas.com/inventor/yinghsin-hsieh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yinghsin Hsieh: Innovator in Microbial Infection Treatment

Introduction

Yinghsin Hsieh is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of microbial infection treatment through his innovative research and patents. His work focuses on developing inhibitors that can effectively combat bacterial infections.

Latest Patents

Yinghsin Hsieh holds 1 patent for his invention titled "SecA inhibitors and methods of making and using thereof." This patent describes inhibitors of SecA, which are compounds that can be utilized to treat or prevent microbial infections, particularly bacterial infections. The methods outlined in his patent provide valuable insights into the development of new therapeutic strategies.

Career Highlights

Yinghsin Hsieh is affiliated with the Georgia State University Research Foundation, Inc. His role at this institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His dedication to innovation has positioned him as a key figure in the fight against microbial infections.

Collaborations

Yinghsin Hsieh has worked alongside esteemed colleagues such as Binghe Wang and Phang-Cheng Tai. These collaborations have further enhanced his research efforts and contributed to the advancement of knowledge in the field of microbial treatment.

Conclusion

Yinghsin Hsieh's contributions to the development of SecA inhibitors represent a significant advancement in the treatment of microbial infections. His innovative work continues to inspire further research and development in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…